Tag Archives: New York

Vireo Health

Vireo Raises Awareness of NY’s Medical Marijuana Program in El Diario and The Jewish Week

Vireo Raises Awareness of NY’s Medical Marijuana Program in El Diario and The Jewish Week

NEW YORK, Feb. 9, 2018 /Weed Wire/ – Vireo Health of New York (“Vireo”), one of five medical marijuana companies currently operating in New York State, is proud to announce new print and digital advertisements appearing in New York publications El Diario and The Jewish Week.

Green Market Report gmr

Green Market Report Announces Launch of Cannabis Stock Index 30 Select Public Companies to Keep An Eye On

NEW YORK, Jan. 31, 2018 /Weed Wire/ — The Green Market Report (GMR), the cannabis industry’s source for credible in depth financial reporting, unveiled the official launch of its industry cannabis stock index.

Central Florida Medical Marijuana Firm Sold in $43M Deal

Central Florida Medical Marijuana Firm Sold in $43M Deal

A New York-based company has purchased a Central Florida pot operation for $43 million in cash and stock, amid expectations that the industry will explode following the voter-approved legalization of medical marijuana more than a year ago.

New York Governor Calls for Feasibility Study to Examine Legalizing Marijuana

New York Governor Calls for Feasibility Study to Examine Legalizing Marijuana

Could New York become the next state to legalize recreational marijuana? On Jan. 16, 2018, New York Gov. Andrew Cuomo announced his proposed FY 2019 state budget, which includes funding for the creation of a feasibility study aimed at understanding the social, health, and criminal justice impact of legalizing recreational marijuana in the state.

REVEL Brings Cannabis Innovators to the East Coast

NEW YORK, Jan. 16, 2018 /Weed Wire/ – REVEL, formerly Cannabis Tech Group, is hosting it’s breakout event “Cannabis + Science” on January 25, 2018 in Soho at Galvanize NYC. REVEL has rebranded and reformatted to a “TED Talk”-style cannabis innovation showcase.

city council

Thursday: Following Votes on Legalizing Marijuana in NH and VT, New York State Legislators Hold Public Hearing on Regulating and Taxing Marijuana for Adult Use

NEW YORK, Jan. 10, 2018 /Weed Wire/ — On January 11, 2018, the New York State Assembly Standing Committees on Codes, Health, and Alcohol and Drug Abuse will convene a public hearing to discuss the Marijuana Regulation and Taxation Act (MRTA, S.3040A/A.3506A), a bill that would legalize the production, distribution, and use of marijuana for adults over the age of 21.

Cannabis Cultural Association Responds to Jeff Sessions Rescinding of Cole Memo

NEW YORK, Jan 5., 2018 /Weed Wire/ — Cannabis Cultural Association, a 501(c)3 nonprofit based in New York which helps marginalized and underrepresented communities engage in the legal cannabis industry, emphasizing criminal justice reform, access to medical cannabis, and adult use legalization issued the following statement on Jeff Sessions decision to rescind the long-standing Cole Memorandum.

Cuomo new york state

New York State Department of Health Announces New Medical Marijuana Regulations

ALBANY, N.Y., Dec. 8, 2017 /Weed Wire/ — The New York State Department of Health today announced the filing of regulations for adoption that will improve the state’s Medical Marijuana Program for patients, practitioners and registered organizations.

Vireo Health

Vireo Kicks Off Holiday Season with NY’s First-Ever ‘Cyber Monday’ Sale of Medical Marijuana

NEW YORK, Nov. 22, 2017 /Weed Wire/ – Today, Vireo Health of New York (“Vireo”), one of only five companies licensed by New York State to cultivate, manufacture and dispense medical marijuana, announced New York’s first-ever “Cyber Monday” sale of medical marijuana products purchased online at vireohealthny.com.

city council

Buffalo Report Shows Stark Marijuana Arrest Disparities

BUFFALO, N.Y., Nov. 14, 2017 /Weed Wire/ — Today, the Partnership for the Public Good, a Buffalo community-based think tank, introduced a report highlighting marijuana arrest disparities in Buffalo, New York.

Green Rush Podcast

KCSA Strategic Communications Launches “The Green Rush” Podcast for the Cannabis Industry

NEW YORK, Nov. 14, 2017 /Weed Wire/ — KCSA Strategic Communications, a fully-integrated communications agency specializing in public relations, investor relations, social media and marketing, is capitalizing on the burgeoning cannabis industry by launching a new podcast called “The Green Rush.”

Governor Signs Five Bills, Adding PTSD as a Qualifying Condition for Medical Marijuana, Waiving Fees and Improving Services for Veterans, and Creating POW/MIA Memorial

NEW YORK, Nov. 11, 2017 /Weed Wire/ — Governor Andrew M. Cuomo today signed five pieces of legislation to further support New York veterans by improving healthcare and services, as well as memorialize veterans throughout New York State in a number of different ways.

city council

Buffalo Press Conference Tuesday: New Report Highlights Alarming Racial Disparities in Buffalo’s Marijuana Arrests

BUFFALO, N.Y., Nov. 9, 2017 /Weed Wire/ — On November 14th, the Partnership for the Public Good will release a report highlighting marijuana prohibition enforcement practices in Buffalo and their disparate impact on communities of color.

Colorado Leads Country in Hemp Production, a Growing Field

Colorado Leads Country in Hemp Production, a Growing Field

Dispensaries might get all the attention, but hemp farmers are getting the acreage – 23,343 acres, to be exact, according to a new study by Vote Hemp, an organization dedicated to advancing the industrial hemp industry. And which state is leading the pack? Colorado, by far.

DirectView Holdings

DirectView Inks Full Servicing Contract for Top-Tier Marijuana Cultivator

NEW YORK, Oct. 25, 2017 /Weed Wire/ – DirectView Holdings, Inc. (OTC:DIRV) (“DirectView” or the “Company”), a company focused on ownership and management of leading video and security technology companies, announced today that the company’s operations now adjoin with the $7.8 billion cannabis industry as a premier supplier of security equipment and infrastructure tailored for cultivators.

First Harvest Identifies Proprietary Hemp Varieties with Excellent Agronomic Qualities

CLARENCE, N.Y., Oct. 19, 2017 /Weed Wire/ — 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and cannabis research, announced today that the Company and the University of Virginia (“UVA”) completed their first successful harvest of hemp plants and identified several promising hemp varieties that could form the foundation for commercial hemp production throughout the legacy tobacco belt region of the United States.

Cuomo new york state

State Granted DEA Permit to Help Growers Import Industrial Hemp Seed and Advance Research Opportunities Industrial Hemp Working Group Meets for First Time Today

NEW YORK, Sept. 20, 2017 /Weed Wire/ — Governor Andrew M. Cuomo today announced an open solicitation for farmers, businesses and research institutions interested in growing and processing industrial hemp as part of the State’s Industrial Hemp Agricultural Research Pilot Program.

ALD Group Limited

The Blinc Group Announces a Partnership With ALD Group Limited and Joinking US Group Inc.

NEW YORK, Sept. 25, 2017 /Weed Wire/ — The Blinc Group announces a partnership with ALD Group Limited and Joinking US Group Inc. Their mission is to develop the ALD Amaze brand and expand Joinking’s distribution foot print on the East Coast.

MariMed

Cannabis Science Pioneer Tikun Olam Expands Partnership with MariMed to Bring Branded Cannabis Products to More U.S. MMJ States

NEWTON, Mass. and NEW YORK, N.Y., Sept. 19, 2017 /Weed Wire/ — Tikun Olam, the world pioneer in cannabis research, and MariMed Inc. (OTCQB:MRMD), a preeminent management company in the U.S. medical cannabis industry, announced an expansion of their licensing agreement for Tikun Olam products to be grown, manufactured and sold through MariMed’s network of managed and affiliated licensed facilities throughout the United States.

city council

Manhattan District Attorney Announces New Policy to Reduce Impact of Marijuana Possession Arrests, Citing Collateral Consequences

NEW YORK, Sept. 6, 2017 /Weed Wire/ – Today, Manhattan District Attorney Cy Vance Jr. announced a shift in his office’s policy for New Yorkers arrested for low level marijuana possession.

Vireo Health

Vireo Health to Participate in $3.8 million NIH Study on Medical Marijuana, Pain and Opioid Use

NEW YORK, Aug. 24, 2017 /Weed Wire/ — The National Institute of Health has awarded a $3.8 million research grant to Albert Einstein College of Medicine and Montefiore Health System for medical marijuana research, and Vireo Health of New York will be partners in the study.

New York State Health Department Issues Improved Medical Marijuana Regulations

New York State Health Department Issues Improved Medical Marijuana Regulations

On Aug. 10, 2017, the New York State Department of Health revealed new regulations for the state’s medical marijuana program. The improved regulations were made in an effort to expand the program, aiming to create a more positive experience for all parties involved.

Department Of Health Proposes Regulations That Would Expand New York’s Medical Marijuana Program

Department Of Health Proposes Regulations That Would Expand New York’s Medical Marijuana Program

The Department of Health just announced the issuance of new proposed regulations that would make changes to the state’s medical marijuana program to improve access. Among other things, they would reduce some of the onerous security requirements for registered organizations, shorten the length of the medical marijuana course certifying practitioners must take from four hours to two, and allow additional types of medical marijuana products to be sold.

This Is the First Long-Term Study on Cannabis and Opioids for Chronic Pain

This Is the First Long-Term Study on Cannabis and Opioids for Chronic Pain

On Aug. 8, 2017, Albert Einstein College of Medicine and Montefiore Health System announced that they had received a grant from the National Institutes of Health to conduct a long-term study on how medical cannabis affects opioid use in adults with chronic pain.

First Long-Term Study on Medical Marijuana's Impact on Opioid Use for Pain

First Long-Term Study on Medical Marijuana’s Impact on Opioid Use for Pain

BRONX, N.Y., Aug. 8, 2017 /Weed Wire/ — The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether me

city council

Advocates Challenge de Blasio to Stop Running from His Record and to Address Racial Disparities in Marijuana Arrests

NEW YORK, Aug. 4, 2017 /Weed Wire/ — Today, Mayor de Blasio’s office published a statement disputing the findings of the Drug Policy Alliance report, “Unjust and Unconstitutional: 60,000 Jim Crow Marijuana Arrests in Mayor de Blasio’s New York.”

Here Are the 5 New Licensees for the New York Medical Marijuana Program

Here Are the 5 New Licensees for the New York Medical Marijuana Program

On Aug. 1, 2017, the NYSDOH announced that it had approved five more registered organizations for the New York Medical Marijuana Program, with each registered organization permitted to cultivate and dispense medical marijuana in the state.

NYSDOH regulations Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana Enhancements, New Registered Organizations

New York State Department of Health Adds Five New Registered Organizations to Medical Marijuana Program

ALBANY, N.Y., Aug. 1, 2017 /Weed Wire/ – The New York State Department of Health today announced that it has authorized five additional registered organizations (ROs) to manufacture and dispense medical marijuana in New York State, an initiative aimed at improving patient access and the geographic distribution of dispensing facilities across the state.

Fiorello Pharmaceuticals

Fiorello Pharmaceuticals Awarded Registered Organization Status for New York State Medical Marijuana Program

NEW YORK, Aug. 1, 2017 /Weed Wire/ — Fiorello Pharmaceuticals, Inc., a pharmaceutical company focused on aiding patients with significant, painful and life-threatening conditions, is proud to announce that it has been selected as a Registered Organization in the expansion of New York State’s Medical Marijuana Program.

industrial hemp

Governor Cuomo Signs Legislation and Announces New Initiatives to Support Growth of Industrial Hemp Industry in New York State

ALBANY, July 12, 2017 /Weed Wire/ — Governor Andrew M. Cuomo today signed legislation and announced new actions to support the emerging industrial hemp industry and boost the agricultural economy in New York State.

86 Percent of NYPD Marijuana Possession Arrests Affect Black and Latino New Yorkers

86 Percent of NYPD Marijuana Possession Arrests Affect Black and Latino New Yorkers

On July 11, 2017, the Drug Policy Alliance announced that a report it had commissioned by the Marijuana Arrest Research Project had been released, revealing that marijuana possession arrests under Mayor Bill de Blasio’s tenure are marked by a high rate of racial disparity.

city council

Tale of Two New Yorks Endures under de Blasio as NYPD Continues Discriminatory Marijuana Arrests

NEW YORK, July 11, 2017 /Weed Wire/ — A new report released today by the Marijuana Arrest Research Project, commissioned by the Drug Policy Alliance, shows that marijuana possession arrests under Mayor de Blasio continue to be marked by extremely high racial disparities, as was the case under the Bloomberg and Giuliani administrations.

Wolters Kluwer

Wolters Kluwer Publishes First Law School Casebook to Focus on Marijuana-Related Legal Issues

NEW YORK, July 10, 2017 /Weed Wire/ — Wolters Kluwer Legal & Regulatory U.S.’s Legal Education business unit today announced it has published Marijuana Law, Policy, and Authority, the first law school casebook focused on this rapidly emerging new practice area.

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

NYSDOH regulations Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana Enhancements, New Registered Organizations

New York State Department of Health Announces Enhancements to Medical Marijuana Program

ALBANY, N.Y., June 22, 2017 /Weed Wire/ – The New York State Department of Health (NYSDOH) today announced several new enhancements to the state’s Medical Marijuana Program as the number of certified patients continues to rise since the addition of chronic pain as a qualifying condition.

Cannabis Tech Group

NYC-Based Cannabis Tech Group Launches to Bridge Burgeoning Tech & Cannabis Industries; Announces First Professional Event: Cannabis + Analytics, Thursday, June 29th at Galvanize NYC in Soho

NEW YORK, June 21, 2017 /Weed Wire/ – The Cannabis Tech Group (CTG), the bi-coastal pioneers whose mission is to bring together the cannabis and technology industries together in a way not yet seen on the East Coast—will hold the first in a nationwide series of events on Thursday, June 29, 2017, from 6:00-9:00 p.m. in Soho at Galvanize NYC.


Page 1 of 512345
Top